Oxaloacetate's Brain Effects
草酰乙酸对大脑的影响
基本信息
- 批准号:8256105
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-15 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAlzheimer&aposs DiseaseBioenergeticsBiogenesisBlood GlucoseBrainCREB1 geneCaenorhabditis elegansCaloric RestrictionCellsCitrate (si)-SynthaseCitratesCitric Acid CycleCoupledDataDicarboxylic AcidsDiseaseElectron TransportEquilibriumFOXO1A geneFutureGene ExpressionGluconeogenesisGlucoseHumanInsulinKainic AcidLaboratoriesLife ExtensionLipid PeroxidationLongevityMAP Kinase GeneMAPK14 geneMAPK3 geneMalatesManufacturer NameMarketingMediatingMitochondriaMitochondrial DNAMonitorMusNADHNeurodegenerative DisordersOxalacetic AcidOxaloacetatesOxidation-ReductionOxygen ConsumptionParkinson DiseasePathway interactionsPharmaceutical PreparationsPhosphorylationPilot ProjectsProteinsProto-Oncogene Proteins c-aktReactionReportingRespirationRouteSeizuresSignal TransductionSignaling Pathway GeneSupplementationTestingTherapeuticWeightagedanti agingbasebrain metabolismcase findingcytochrome cdetection of nutrientdiabeticdietary supplementsenzyme activityglucose tolerancehuman FRAP1 proteinin vivointerestintraperitonealmimeticsneuroblastoma celloxidationpreventresearch studytrend
项目摘要
DESCRIPTION (provided by applicant): Enhancing brain mitochondrial respiration could conceivably benefit diseases with reduced brain electron transport chain enzyme activities. This includes several common diseases such as Alzheimer's disease and Parkinson's disease. We and others have proposed that shifting cell cytosolic redox balances towards a more oxidized state might increase mitochondrial respiration and that this may have therapeutic consequences. To accomplish this manipulation my laboratory has screened a number of compounds, and preliminary experiments suggest oxaloacetate (OAA), whose reduction to malate is coupled to the oxidation of NADH to NAD+, holds particular promise. OAA, a dicarboxylic acid, is a Krebs cycle and gluconeogenesis intermediate. You can purchase it as a nutritional supplement. One manufacturer markets it as a caloric restriction mimetic and "longevity supplement". These claims are based on a 2009 study in which OAA-treated C. elegans worms outlived untreated worms. Two in vivo OAA vertebrate studies are also reported. The first is a 1968 study of human diabetics, which found that OAA treatment lowered blood glucose levels. The second is a 2003 study performed on mice, which found OAA prevented kainic acid-induced seizures, brain mtDNA degradation, and lipid peroxidation. Aside from these three studies OAA supplementation effects are essentially unknown. In preliminary studies we found adding OAA to neuroblastoma cells robustly increased mitochondrial oxygen consumption. In mice, we found systemically administered OAA increased brain PGC1a levels. Brain TNFa expression, on the other hand, was reduced and ERK1/2 phosphorylation trended in the same direction. Based on conceptual and preliminary data considerations OAA therefore warrants further consideration as a pro-respiration, pro-mitochondrial biogenesis agent that may act as a brain-penetrating caloric restriction mimetic. I am therefore hypothesizing systemically administered OAA will activate pathways that contribute to or mediate brain mitochondrial biogenesis. Support for this hypothesis would justify additional, more detailed studies of how OAA supplements affect brain metabolism, signaling pathways, and gene expression. The pilot studies we now propose will further test how systemically administered OAA affects brain mitochondrial biogenesis, proteins and pathways that are implicated in mitochondrial biogenesis, and nutrient sensing pathways in OAA-treated mice. In Aim 1 we will characterize brain bioenergetics and bioenergetics-related pathways in young OAA-treated mice. In Aim 2 we will characterize brain bioenergetics and bioenergetics-related pathways in aged mice treated with OAA over a 12-month period. If the studies I now propose confirm and extend our preliminary findings, the case for developing OAA or OAA-like drugs for the treatment of diseases with reduced brain bioenergetics will be immensely strengthened.
PUBLIC HEALTH RELEVANCE: We will test the ability of oxaloacetic acid (OAA) to activate brain mitochondrial biogenesis, proteins and pathways implicated in mitochondrial biogenesis, and nutrient sensing pathways in mice. Our hypothesis is that systemically administered OAA will activate pathways that contribute to or mediate brain mitochondrial biogenesis. Our preliminary data show OAA functions as a pro-respiration, pro-mitochondrial biogenesis agent that acts as a brain-penetrating caloric restriction mimetic; confirming and extending our preliminary data would support the case for developing OAA or OAA-like drugs for the treatment of diseases with reduced brain bioenergetic capacity.
描述(由申请人提供):增强脑线粒体呼吸可能有益于脑电子传递链酶活性降低的疾病。这包括几种常见的疾病,如阿尔茨海默病和帕金森病。我们和其他人已经提出,将细胞胞质氧化还原平衡向更氧化的状态转移可能会增加线粒体呼吸,这可能具有治疗效果。为了完成这种操作,我的实验室筛选了许多化合物,初步实验表明草酰乙酸(OAA),其还原为苹果酸与NADH氧化为NAD+相结合,具有特别的前景。OAA是一种二羧酸,是克雷布斯循环和异源生成的中间体。您可以将其作为营养补充剂购买。一家制造商将其作为热量限制模拟物和“长寿补充剂”进行销售。这些说法是基于2009年的一项研究,其中OAA治疗的C。秀丽蠕虫比未处理的蠕虫活得更久。还报道了两项体内OAA脊椎动物研究。第一项是1968年对人类糖尿病患者的研究,该研究发现OAA治疗可以降低血糖水平。第二个是2003年对小鼠进行的研究,发现OAA可以防止红藻氨酸诱导的癫痫发作,大脑mtDNA降解和脂质过氧化。除了这三项研究之外,补充OAA的效果基本上是未知的。在初步研究中,我们发现向神经母细胞瘤细胞中添加OAA强烈增加了线粒体耗氧量。在小鼠中,我们发现全身给予OAA会增加大脑PGC 1a水平。另一方面,脑TNF α表达减少,ERK 1/2磷酸化趋势相同。基于概念和初步数据考虑,OAA因此值得进一步考虑作为促呼吸、促线粒体生物发生剂,其可充当脑穿透热量限制模拟物。因此,我假设全身给予OAA将激活有助于或介导脑线粒体生物合成的途径。支持这一假设将证明额外的,更详细的研究如何OAA补充剂影响大脑代谢,信号通路和基因表达。我们现在提出的试点研究将进一步测试全身给予OAA如何影响脑线粒体生物合成,与线粒体生物合成有关的蛋白质和途径,以及OAA治疗小鼠的营养感应途径。在目标1中,我们将描述年轻OAA处理小鼠的脑生物能量学和生物能量学相关通路。在目标2中,我们将描述在12个月的时间内用OAA治疗的老年小鼠的脑生物能量学和生物能量学相关通路。如果我现在提出的研究证实并扩展了我们的初步发现,那么开发OAA或OAA样药物来治疗大脑生物能量减少的疾病的情况将大大加强。
公共卫生关系:我们将测试草酰乙酸(OAA)激活小鼠脑线粒体生物合成、线粒体生物合成中涉及的蛋白质和途径以及营养感应途径的能力。我们的假设是,全身给予OAA将激活有助于或介导脑线粒体生物合成的途径。我们的初步数据显示OAA作为促呼吸、促线粒体生物发生剂起作用,其充当脑穿透热量限制模拟物;确认和扩展我们的初步数据将支持开发OAA或OAA样药物用于治疗脑生物能量能力降低的疾病的情况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUSSELL H. SWERDLOW其他文献
RUSSELL H. SWERDLOW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUSSELL H. SWERDLOW', 18)}}的其他基金
University of Kansas Alzheimers Disease Center P30 Neuropathology supplement
堪萨斯大学阿尔茨海默病中心 P30 神经病理学补充
- 批准号:
10741516 - 财政年份:2021
- 资助金额:
$ 7.55万 - 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
- 批准号:
10466947 - 财政年份:2021
- 资助金额:
$ 7.55万 - 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
- 批准号:
10666543 - 财政年份:2021
- 资助金额:
$ 7.55万 - 项目类别:
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
堪萨斯大学阿尔茨海默病研究中心 (KU ADRC)
- 批准号:
10264622 - 财政年份:2021
- 资助金额:
$ 7.55万 - 项目类别:
Mechanistic Basis of the mtDNA Haplogroup J-Alzheimer's Disease Association
mtDNA 单倍群 J-阿尔茨海默病协会的机制基础
- 批准号:
10565875 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
Mechanistic Basis of the mtDNA Haplogroup J-Alzheimer's Disease Association
mtDNA 单倍群 J-阿尔茨海默病协会的机制基础
- 批准号:
10353367 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 7.55万 - 项目类别:
Research Grant